Evid Invest
Holders — by stockHoldings — by fund

Blue Owl Capital Holdings LP

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 1858703

$664.5M

disclosed book value

76

positions

36%

largest position share

Positions, as of 2026-06-30

top 76 of 76 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1SPCXSPACE EXPLORATION TECHN CORP1.4M$239.0M36%
2AKTIS ONCOLOGY INC3.1M$99.0M14.9%
3CGEMCULLINAN THERAPEUTICS INC1.5M$28.0M4.2%
4LARIMAR THERAPEUTICS INC9.2M$27.9M4.2%
5NUVEEN CHURCHILL DIRECT LEND2.1M$26.6M4%
6MAPLIGHT THERAPEUTICS INC729,929$26.2M3.9%
7COFCAPITAL ONE FINL CORP119,757$24.0M3.6%
8OBDCBLUE OWL CAPITAL CORPORATION2.0M$22.2M3.3%
9DEEP FISSION INC1.3M$14.7M2.2%
10DELLDELL TECHNOLOGIES INC32,961$14.2M2.1%
11HOLLEY INC4.4M$11.2M1.7%
12EYPTEYEPOINT INC762,594$10.9M1.6%
13SAGIMET BIOSCIENCES INC1.3M$9.7M1.5%
14CRVSCORVUS PHARMACEUTICALS INC608,600$9.1M1.4%
15ARTIVA BIOTHERAPEUTICS INC874,542$8.5M1.3%
16CMPXCOMPASS THERAPEUTICS INC3.6M$7.9M1.2%
17CONDUENT INC5.0M$7.4M1.1%
18RYTMRHYTHM PHARMACEUTICALS INC61,455$6.8M1%
19COMPASS PATHWAYS PLC450,000$6.4M1%
20RAREULTRAGENYX PHARMACEUTICAL IN182,638$6.1M0.9%
21PVLAPALVELLA THERAPEUTICS INC NE36,259$5.5M0.8%
22IMAGENEBIO INC917,692$5.4M0.8%
23COMPASS PATHWAYS PLCCALL1.7M$5.2M0.8%
24VRDNVIRIDIAN THERAPEUTICS INC260,000$4.8M0.7%
25IMMIX BIOPHARMA INC437,552$4.5M0.7%
26ORICORIC PHARMACEUTICALS INC400,000$4.3M0.7%
27LENZLENZ THERAPEUTICS INC756,722$4.3M0.6%
28AQUESTIVE THERAPEUTICS INC942,932$3.9M0.6%
29STWDSTARWOOD PPTY TR INC196,355$3.2M0.5%
30EVOMMUNE INC180,000$2.4M0.4%
31ELEDON PHARMACEUTICALS INC566,509$2.2M0.3%
32CABALETTA BIO INC714,710$2.2M0.3%
33CHYMCHIME FINL INC89,878$1.8M0.3%
34CONTEXT THERAPEUTICS INC2.9M$1.6M0.2%
35WW INTL INC84,399$1.3M0.2%
36MARKER THERAPEUTICS INC554,250$814,7480.1%
37ERASCA INCCALL100,000$795,0000.1%
38ADC THERAPEUTICS SA733,568$784,9180.1%
39CYBIN INC59,911$396,0120.1%
40FOLD HLDGS INC856,632$385,4840.1%
41NIOCORP DEVS LTD268,280$380,9580.1%
42ELEDON PHARMACEUTICALS INCCALL200,000$285,0000%
43REZOLVE AI PLC235,121$213,9600%
44BRAND ENGAGEMENT NETWORK INC1.5M$203,5330%
45PIPRPIPER SANDLER COMPANIES2,428$175,6420%
46ENGENE THERAPEUTICS INC511,177$148,1900%
47LARIMAR THERAPEUTICS INCCALL728,600$145,7200%
48CELCCELCUITY INC1,249$130,6700%
49COMPASS THERAPEUTICS INCCALL303,800$106,3300%
50STABLECOINX INC250,000$102,5000%
51ETENERGY TRANSFER L P5,326$101,8330%
52CAICARIS LIFE SCIENCES INC4,711$83,9500%
53VODVODAFONE GROUP PLC5,371$71,0050%
54DAVE INC28,750$68,4250%
55MURANO GLOBAL INVT PLC261,875$62,8500%
56ALPHA MODUS HLDGS INC1.9M$55,6400%
57ROADZEN INC225,000$42,7500%
58ALPHA MODUS HLDGS INC9,853$41,9740%
59AEON BIOPHARMA INC42,353$30,4940%
60SOUTHLAND HLDGS INC860,302$25,8090%
61BLUE GOLD LTD175,000$21,0000%
62SHF HOLDINGS INC75,897$18,2150%
63BLACKSKY TECHNOLOGY INC350,000$17,5000%
64TEVOGEN BIO HLDGS INC200,000$12,0000%
65ZEO ENERGY CORP250,000$10,0000%
66LIVEWIRE GROUP INC400,000$8,0000%
67NVNI GROUP LIMITED200,000$6,0000%
68KATAPULT HOLDINGS INC5,421$5,3730%
69CID HOLDCO INC444,515$4,4450%
70BAIRD MED INVT HLDGS LTD100,000$4,0000%
71PAGAYA TECHNOLOGIES LTD48,661$2,4330%
72STARDUST PWR INC16,666$2,1670%
73LIMINATUS PHARMA INC.50,000$2,0000%
74WALDENCAST PLC33,333$1,6670%
75XBP GLOBAL HOLDINGS INC24,778$1,4870%
76ASPIRE BIOPHARMA HLDGS INC50,000$1,0000%

Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.